Article
Reinforced regimen of interferon alfa-2a reduces the incidence of cirrhosis in patients with chronic hepatitis C: a multicentre randomised trial. Multicentre GER-CYT-04 Group.
Journal of hepatology - 1 Aug 1998
Degos F, Daurat V, Chevret S, Gayno S, Bastie A, Riachi G, Bartolomei-Portal I, Barange K, Moussalli J, Naveau S, Bailly F, Chaumet-Riffaud P, Chastang C
Abstract excerpt
BACKGROUND/AIMS: Our aim was to assess and compare the long-term effect of interferon at standard (6 months) and reinforced dose and duration regimens in chronic hepatitis C. METHODS: A multicentre institutional trial included 244 previously untreated patients with chronic hepatitis C, without ci...
Topics
- Adult
- Aged
- Alanine Transaminase
- Antiviral Agents
- Clinical Protocols
- DNA, Viral
- Drug Administration Schedule
- Female
- Follow-Up Studies
- France
- Genotype
- Hepacivirus
- Hepatitis C Antibodies
- Hepatitis C, Chronic